Which of the following Anti-leprotic drugs is not given in blister packs of NLEP?
**Core Concept**
The National Leprosy Eradication Programme (NLEP) in India uses a multi-drug therapy (MDT) regimen to treat leprosy. The MDT regimen includes a combination of rifampicin, clofazimine, and dapsone. The drugs are packaged in blister packs to ensure patient adherence and to prevent the development of drug resistance.
**Why the Correct Answer is Right**
The correct answer is rifampicin. Rifampicin is an essential component of the MDT regimen for leprosy, but it is not packaged in blister packs as part of the NLEP. The blister packs are designed to provide a fixed dose of clofazimine and dapsone, which are taken together twice a day for a specified period. Rifampicin, on the other hand, is usually given once a month.
**Why Each Wrong Option is Incorrect**
**Option A:** Clofazimine is one of the drugs packaged in blister packs as part of the NLEP.
**Option B:** Dapsone is also packaged in blister packs as part of the NLEP.
**Option C:** The third drug in the blister pack is actually rifampicin is not correct, but the blister packs do contain a combination of Clofazimine and Dapsone.
**Clinical Pearl / High-Yield Fact**
The NLEP blister packs are designed to simplify treatment and improve patient adherence. The blister packs contain a fixed dose of clofazimine and dapsone, which reduces the risk of medication errors and ensures that patients receive the correct treatment.
**Correct Answer:** C.